International Recognition Procedure

From January 2024, the MHRA is adopting the International Recognition Procedure, reflecting a strategic pivot towards an independent and collaborative regulatory framework for swift and secure drug authorizations in the UK.

Our Market Access team has outlined everything that pharmaceutical companies will need to know to prepare for the new policy in this downloadable resource. Please complete the form to the right to download the resource.